Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Classifica tra le azioni #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Prezzo delle azioni
$2.10
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$104.43M
Variazione (1 giorno)
-2.10%
Variazione (1 anno)
-
Paese
US
Scambia Polaryx Therapeutics, Inc. Common Stock (PLYX)

Categoria

Storico del rendimento da dividendi per Polaryx Therapeutics, Inc. Common Stock (PLYX)
Il rendimento da dividendi (TTM) di Polaryx Therapeutics, Inc. Common Stock (simbolo azionario: PLYX) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Polaryx Therapeutics, Inc. Common Stock (PLYX) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH